ALEXANDRA STARZHEVSKIY: Open Payments
NPI 1982265864 · PLANT CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,212 in 59 payments from 9 companies in 2025. Trend: 2023 $1,056 · 2024 $1,021 · 2025 $1,212
Food & beverage: $1,212
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $382 |
| Amgen Inc. | 13 | $192 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $154 |
| Lilly USA, LLC | 8 | $145 |
| AstraZeneca Pharmaceuticals LP | 5 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $97 |
| UCB, Inc. | 2 | $58 |
| Dexcom, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Ozempic, JARDIANCE, OTEZLA, AIRSUPRA, Wegovy, Kerendia, MOUNJARO, Bimzelx.
Industry payments across FL — which companies pay providers there.
